Tower Research Capital (TRC)’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,614
| Closed | -$79.9K | – | 6285 |
|
|
2023
Q4 | $79.9K | Buy |
5,614
+5,379
| +2,289% | +$76.6K | ﹤0.01% | 2808 |
|
|
2023
Q3 | $2.7K | Buy |
+235
| New | +$2.7K | ﹤0.01% | 5114 |
|
|
2023
Q2 | – | Sell |
-20,440
| Closed | -$182K | – | 6448 |
|
|
2023
Q1 | $182K | Buy |
20,440
+20,437
| +681,233% | +$182K | 0.01% | 1421 |
|
|
2022
Q4 | $0 | Sell |
3
-39
| -93% | – | ﹤0.01% | 6571 |
|
|
2022
Q3 | $0 | Buy |
+42
| New | – | ﹤0.01% | 6667 |
|